Gilead Sciences (GILD) Stock Forecast & Price Target

GILD$168.08+0.13 +0.08%
Drug Manufacturers - GeneralMega Cap
Compare
Market cap$208.48BEnterprise value$236.14BRevenue (TTM)$30.99BMarket positionTop 5%

Score

37
Bearish
Value
30
Quality
44
Growth
38

Gilead Sciences, Inc. price target

GILD
Low$126.00
Average$165.38
High$196.00
Upside vs current price-1.6%

The average target of $165.38 is -1.6% versus the current GILD price of $168.08.

Gilead Sciences, Inc. analyst ratings

RatingAnalysts
Strong buy6
Buy16
Hold5
Sell0
Strong sell1
ConsensusBuy

28 analysts cover GILD.

Gilead Sciences, Inc. EPS and revenue estimates

GILD shows the next fiscal years with at least three analysts: 2026 EPS $-0.82, 2027 EPS $10.10. A thinner year is left off this table.

Fiscal yearEPS estimateRevenue estimate
2026$-0.82$31.25B
2027$10.10$33.47B

Is Gilead Sciences, Inc. a buy or sell?

Of the 28 analysts covering Gilead Sciences, Inc., 22 rate it a buy (6 strong buy and 16 buy), 5 rate it a hold, and 1 rates it a sell (0 sell and 1 strong sell).

The GILD consensus label is Buy, beside 22 buy-side ratings and 1 sell-side ratings.

The average target of $165.38 implies -1.6% versus the current price of $168.08.

Those 28 ratings on GILD are a headcount, and the label on file is Buy.

Reading the Gilead Sciences, Inc. forecast

The GILD target range is wide: $126.00 at the low end, $165.38 in the middle, and $196.00 at the top.

Set next to the $168.08 GILD quote, that average is -1.6%.

Ratings on the Gilead Sciences, Inc. cluster: 22 of 28 analysts are on the buy side, 5 are at hold, and 1 is on the sell side, and the published consensus is Buy.

Recent GILD revisions are two-sided: 0 upgrades and 1 downgrades.

The average GILD target over the last month is $173.11, above the $167.17 average of the last quarter.

28 analysts publish on GILD, so one note does not swing the average by itself.

Gilead Sciences, Inc. forecast questions

What is the GILD price target?

The published range for GILD is $126.00 to $196.00, with an average of $165.38. That average is -1.6% versus the current price of $168.08.

Is Gilead Sciences, Inc. a buy or sell?

Of the 28 analysts covering Gilead Sciences, Inc., 22 rate it a buy, 5 rate it a hold, and 1 rates it a sell. The consensus is Buy, and the GILD headcount is 22 buy, 5 hold, and 1 sell.

What is the EPS estimate for Gilead Sciences, Inc.?

Analyst EPS estimates for Gilead Sciences, Inc.: 2026 $-0.82, 2027 $10.10.

What is the revenue estimate for Gilead Sciences, Inc.?

Analyst revenue estimates for Gilead Sciences, Inc.: 2026 $31.25B, 2027 $33.47B.

How many analysts cover GILD?

28 analysts cover GILD. Their consensus on GILD is Buy, across those 28.

GILD price $168.08 +0.13 +0.08%

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener